Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MabThera Post Marketing Observational Study in TNF-IR Patients to Assess Efficacy and Safety of REPeated Courses in routinE ClinicAl pracTice

NCT01196780 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01196780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01196780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MabThera Post Marketing Observational Study in TNF-IR Patients to Assess Efficacy and Safety of REPeated Courses in routinE ClinicAl pracTice
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Terminated
Start date
February 28, 2010
Completion date
October 31, 2015
Enrollment
1,240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis